The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ARGENX SE | Sponsored ADR | 04016X101 | 927,770,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| ARROWHEAD PHARMACEUTICALS INC | Common | 04280A100 | 925,591,288 | 11,355,555 | SH | SOLE | 11,355,555 | 0 | 0 | ||
| ASCENDIS PHARMA | ORDINARY SHARES | K08588103 | 1,363,235,526 | 5,111,111 | SH | SOLE | 5,111,111 | 0 | 0 | ||
| AVALO THERAPEUTICS | Common | 05338F306 | 43,119,994 | 2,333,333 | SH | SOLE | 2,333,333 | 0 | 0 | ||
| CELCUITY INC | Common | 15102K100 | 355,708,000 | 3,400,000 | SH | SOLE | 3,400,000 | 0 | 0 | ||
| CYTOKINETICS INC | Common | 23282W605 | 425,949,915 | 4,999,999 | SH | SOLE | 4,999,999 | 0 | 0 | ||
| DAMORA THERAPEUTICS INC | Common | 36322Q206 | 98,395,830 | 3,783,000 | SH | SOLE | 3,783,000 | 0 | 0 | ||
| DEFINIUM THERAPEUTICS INC | Common | 24477V105 | 338,165,292 | 7,188,888 | SH | SOLE | 7,188,888 | 0 | 0 | ||
| FAETH THERAPEUTICS INC | COMMON | 81728A207 | 36,100,975 | 1,444,039 | SH | SOLE | 1,444,039 | 0 | 0 | ||
| GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 48,384,000 | 1,800,000 | SH | SOLE | 1,800,000 | 0 | 0 | ||
| HEMAB THERAPEUTICS HLDGS INC | Common | 423494103 | 70,710,760 | 1,925,150 | SH | SOLE | 1,925,150 | 0 | 0 | ||
| KRYSTAL BIOTECH INC | Common | 501147102 | 1,073,713,003 | 2,888,888 | SH | SOLE | 2,888,888 | 0 | 0 | ||
| KYMERA THERAPEUTICS INC | Common | 501575104 | 857,129,238 | 7,474,747 | SH | SOLE | 7,474,747 | 0 | 0 | ||
| LEXEO THERAPEUTICS INC | Common | 52886X107 | 6,932,175 | 1,489,189 | SH | SOLE | 1,489,189 | 0 | 0 | ||
| MADRIGAL PHARMACEUTICALS INC | Common | 558868105 | 984,408,154 | 1,833,333 | SH | SOLE | 1,833,333 | 0 | 0 | ||
| OCULAR THERAPEUTIX INC | Common | 67576A100 | 123,142,800 | 12,540,000 | SH | SOLE | 12,540,000 | 0 | 0 | ||
| REVOLUTION MEDICINES INC | Common | 76155X100 | 430,182,160 | 2,297,000 | SH | SOLE | 2,297,000 | 0 | 0 | ||
| SEPTERNA INC | Common | 81734D104 | 44,792,875 | 1,337,500 | SH | SOLE | 1,337,500 | 0 | 0 | ||
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | 351,836,637 | 6,555,555 | SH | SOLE | 6,555,555 | 0 | 0 | ||
| TAYSHA GENE THERAPIES INC | Common | 877619106 | 162,683,327 | 23,888,888 | SH | SOLE | 23,888,888 | 0 | 0 | ||
| UNIQURE NV | Common | N90064101 | 309,881,409 | 6,727,777 | SH | SOLE | 6,727,777 | 0 | 0 | ||
| UNITED THERAPEUTICS CORP | Common | 91307C102 | 1,505,082,912 | 2,777,777 | SH | SOLE | 2,777,777 | 0 | 0 | ||
| VERA THERAPEUTICS INC | Common | 92337R101 | 245,612,034 | 5,723,888 | SH | SOLE | 5,723,888 | 0 | 0 | ||
| VIRIDIAN THERAPEUTICS INC | Common | 92790C104 | 45,925,000 | 2,500,000 | SH | SOLE | 2,500,000 | 0 | 0 | ||
| WHITEHAWK THERAPEUTICS INC | Common | 00032Q104 | 13,050,261 | 2,849,402 | SH | SOLE | 2,849,402 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | Common | 98420N105 | 348,746,620 | 5,777,777 | SH | SOLE | 5,777,777 | 0 | 0 | ||